RARRES2 is Downregulated in Isocitrate Dehydrogenase 1 Mutant Glioma Patients and Served as an Unfavorable Prognostic Factor of Glioma

被引：0

作者：

Wang, Haiwei ^{[1
]}

Wang, Xinrui ^{[1
]}

Xu, Liangpu ^{[1
]}

Zhang, Ji ^{[2
]}

机构：

[1] Fujian Med Univ, Fujian Matern & Child Hlth Hosp, Affiliated Hosp, Fuzhou, Fujian, Peoples R China

[2] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Shanghai, Peoples R China

来源：

WORLD NEUROSURGERY | 2023年 / 176卷

关键词：

Glioblastoma multiforme; IDH1; mutation; Lower-grade glioma; Prognosis; RARRES2; INTEGRATIVE GENOMIC ANALYSIS; ACUTE MYELOID-LEUKEMIA; IDH2; MUTATIONS; EXPRESSION; GROWTH; CELLS; CLASSIFICATION; CHEMERIN; REVEALS;

D O I：

10.1016/j.wneu.2023.05.109

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

BACKGROUND: Mutations in isocitrate dehydrogenase 1 (IDH1) induce extensive transcriptional alterations to promote glioma development. However, IDH1 mutation contributes the better clinical outcomes of glioma. Further -nderstanding the transcriptional and DNA methylation changes mediated by IDH1 mutation will provide new therapeutic targets for glioma.METHODS: Public glioma cohorts were collected and processed using R software. The transcriptional changes mediated by IDH1 mutation were determined and presented using heatmap. The differentially expressed genes in IDH1 mutant glioma were overlapped using TBtools. The prog-nostic effects of IDH1 regulated genes were determined by Kaplan-Meier survival analysis.RESULTS: Retinoic acid receptor responder 2 (RARRES2) was upregulated in IDH1 wild type lower-grade glioma (LGG) patients, and higher expression levels of RARRES2 were associated with worse clinical outcomes of LGG. Moreover, IDH1 wild type LGG patients with higher expression levels of RARRES2 had even worse overall survival. Compared with LGG, RARRES2 was upregulated in grade IV glioma (glioblastoma multiforme, GBM). Also, RARRES2 represented an unfavorable prognostic factor of glioma. In GBM, RARRES2 was also associated with IDH1 mutation. In both LGG and GBM, IDH1 mutation induced extensive DNA hypermethylation, and more than half genes that were downregulated in IDH1 mutant glioma werecontributed by DNA hypermethylation. RARRES2 was also hypermethylated in IDH1 mutant LGG or GBM patients. Furthermore, RARRES2 hypomethylation was an unfavor-able prognostic factor in patients with LGG.CONCLUSIONS: RARRES2 was downregulated by IDH1 mutation and served as an unfavorable prognostic factor in glioma.

引用

页码：E610 / E622

页数：13

共 50 条

[21] Gene expression signature-based prognostic risk score in patients with glioblastoma [J].

Kawaguchi, Atsushi ;

Yajima, Naoki ;

Tsuchiya, Naoto ;

Homma, Jumpei ;

Sano, Masakazu ;

Natsumeda, Manabu ;

Takahashi, Hitoshi ;

Fujii, Yukihiko ;

Kakuma, Tatsuyuki ;

Yamanaka, Ryuya .

CANCER SCIENCE, 2013, 104 (09) :1205-1210

[22] Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation [J].

Li, Sichen ;

Chou, Arthur P. ;

Chen, Weidong ;

Chen, Ruihuan ;

Deng, Yuzhong ;

Phillips, Heidi S. ;

Selfridge, Julia ;

Zurayk, Mira ;

Lou, Jerry J. ;

Everson, Richard G. ;

Wu, Kuan-Chung ;

Faull, Kym F. ;

Cloughesy, Timothy ;

Liau, Linda M. ;

Lai, Albert .

NEURO-ONCOLOGY, 2013, 15 (01) :57-68

[23]

Lin W, 2011, CLIN LAB, V57, P879

[24] RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma [J].

Liu-Chittenden, Y. ;

Jain, M. ;

Gaskins, K. ;

Wang, S. ;

Merino, M. J. ;

Kotian, S. ;

Gara, S. Kumar ;

Davis, S. ;

Zhang, L. ;

Kebebew, E. .

ONCOGENE, 2017, 36 (25) :3541-3552

[25] The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary [J].

Louis, David N. ;

Perry, Arie ;

Reifenberger, Guido ;

von Deimling, Andreas ;

Figarella-Branger, Dominique ;

Cavenee, Webster K. ;

Ohgaki, Hiroko ;

Wiestler, Otmar D. ;

Kleihues, Paul ;

Ellison, David W. .

ACTA NEUROPATHOLOGICA, 2016, 131 (06) :803-820

[26] IDH mutation impairs histone demethylation and results in a block to cell differentiation [J].

Lu, Chao ;

Ward, Patrick S. ;

Kapoor, Gurpreet S. ;

Rohle, Dan ;

Turcan, Sevin ;

Abdel-Wahab, Omar ;

Edwards, Christopher R. ;

Khanin, Raya ;

Figueroa, Maria E. ;

Melnick, Ari ;

Wellen, Kathryn E. ;

O'Rourke, Donald M. ;

Berger, Shelley L. ;

Chan, Timothy A. ;

Levine, Ross L. ;

Mellinghoff, Ingo K. ;

Thompson, Craig B. .

NATURE, 2012, 483 (7390) :474-U130

[27] Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome [J].

Mardis, Elaine R. ;

Ding, Li ;

Dooling, David J. ;

Larson, David E. ;

McLellan, Michael D. ;

Chen, Ken ;

Koboldt, Daniel C. ;

Fulton, Robert S. ;

Delehaunty, Kim D. ;

McGrath, Sean D. ;

Fulton, Lucinda A. ;

Locke, Devin P. ;

Magrini, Vincent J. ;

Abbott, Rachel M. ;

Vickery, Tammi L. ;

Reed, Jerry S. ;

Robinson, Jody S. ;

Wylie, Todd ;

Smith, Scott M. ;

Carmichael, Lynn ;

Eldred, James M. ;

Harris, Christopher C. ;

Walker, Jason ;

Peck, Joshua B. ;

Du, Feiyu ;

Dukes, Adam F. ;

Sanderson, Gabriel E. ;

Brummett, Anthony M. ;

Clark, Eric ;

McMichael, Joshua F. ;

Meyer, Rick J. ;

Schindler, Jonathan K. ;

Pohl, Craig S. ;

Wallis, John W. ;

Shi, Xiaoqi ;

Lin, Ling ;

Schmidt, Heather ;

Tang, Yuzhu ;

Haipek, Carrie ;

Wiechert, Madeline E. ;

Ivy, Jolynda V. ;

Kalicki, Joelle ;

Elliott, Glendoria ;

Ries, Rhonda E. ;

Payton, Jacqueline E. ;

Westervelt, Peter ;

Tomasson, Michael H. ;

Watson, Mark A. ;

Baty, Jack ;

Heath, Sharon .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11) :1058-1066

[28] Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma [J].

Noushmehr, Houtan ;

Weisenberger, Daniel J. ;

Diefes, Kristin ;

Phillips, Heidi S. ;

Pujara, Kanan ;

Berman, Benjamin P. ;

Pan, Fei ;

Pelloski, Christopher E. ;

Sulman, Erik P. ;

Bhat, Krishna P. ;

Verhaak, Roel G. W. ;

Hoadley, Katherine A. ;

Hayes, D. Neil ;

Perou, Charles M. ;

Schmidt, Heather K. ;

Ding, Li ;

Wilson, Richard K. ;

Van Den Berg, David ;

Shen, Hui ;

Bengtsson, Henrik ;

Neuvial, Pierre ;

Cope, Leslie M. ;

Buckley, Jonathan ;

Herman, James G. ;

Baylin, Stephen B. ;

Laird, Peter W. ;

Aldape, Kenneth .

CANCER CELL, 2010, 17 (05) :510-522

[29] IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response [J].

Nunez, Felipe J. ;

Mendez, Flor M. ;

Kadiyala, Padma ;

Alghamri, Mahmoud S. ;

Savelieff, Masha G. ;

Garcia-Fabiani, Maria B. ;

Haase, Santiago ;

Koschmann, Carl ;

Calinescu, Anda-Alexandra ;

Kamran, Neha ;

Saxena, Meghna ;

Patel, Rohin ;

Carney, Stephen ;

Guo, Marissa Z. ;

Edwards, Marta ;

Ljungman, Mats ;

Qin, Tingting ;

Sartor, Maureen A. ;

Tagett, Rebecca ;

Venneti, Sriram ;

Brosnan-Cashman, Jacqueline ;

Meeker, Alan ;

Gorbunova, Vera ;

Zhao, Lili ;

Kremer, Daniel M. ;

Zhang, Li ;

Lyssiotis, Costas A. ;

Jones, Lindsey ;

Hertin, Cameron J. ;

Ross, James L. ;

Hambardzumyan, Dolores ;

Hervey-Jumper, Shawn ;

Figueroa, Maria E. ;

Lowenstein, Pedro R. ;

Castro, Maria G. .

SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (479)

[30] Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment [J].

Pachynski, Russell K. ;

Wang, Ping ;

Salazar, Nicole ;

Zheng, Yayue ;

Nease, Leona ;

Rosalez, Jesse ;

Leong, Weng-In ;

Virdi, Gurpal ;

Rennier, Keith ;

Shin, Woo Jae ;

Viet Nguyen ;

Butcher, Eugene C. ;

Zabel, Brian A. .

FRONTIERS IN IMMUNOLOGY, 2019, 10

← 1 2 3 4 5 →